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Abstract: Thoracoabdominal aneurysms account for roughly 3% of identified aneurysms
annually in the United States. Advancements in endovascular techniques and devices have broadened their application to these complex surgical problems. This paper will focus on the current
state of endovascular thoracoabdominal aneurysm repair, including specific considerations in
patient selection, operative planning, and perioperative complications. Both total endovascular
and hybrid options will be considered.
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Aneurysms of the thoracoabdominal aorta (TAAs) are relatively uncommon in the
spectrum of aneurysmal disease, accounting for only 3% of diagnosed aneurysms in
the United States (US).1 This results in roughly ten new aneurysms per 100,000 personyears.2,3 The initial classification schema for TAAs was described in 1986 by Crawford
and Coselli.4 This included four subtypes of varying extent of the thoracic and abdominal aorta. In 1999 Safi and Miller modified the initial Crawford classification by adding
a fifth subtype (Figure 1).5 Both female sex and the presence of Chronic Obstructive
Pulmonary Disease (COPD) have been associated with increased risk of rupture.
While female sex has been associated with delayed time to aneurysm formation, the
absolute risk of rupture is increased in size for size match cohorts. COPD has been
associated with a 3.6-fold higher risk of rupture.6 Longitudinal studies have shown
that for every 1 cm growth over 5 cm, the risk of rupture doubles.6 Untreated, nearly
80% will progress to rupture.7 At 6–6.5 cm, that annualized risk of rupture is roughly
7%; as such, this is often the threshold for intervention.8
The first published reports of TAA repair were in 1955 by Etheredge et al and
Rob.9,10 These aneurysms were approached via a left lateral thoracoabdominal incision and included reconstruction of the visceral segment of the abdominal aorta.
Two years prior to this, De Bakey and Cooley reported their experience with isolated
thoracic aortic aneurysms.11 Over the next 10 years, they amassed 42 patients who
underwent repair utilizing Dacron interposition grafts.12 In 1974, E Stanley Crawford
reported his experience with visceral pedicles, including en bloc anastomosis of the
celiac, superior mesenteric artery (SMA), and right renal, followed by isolated left
renal reimplantation.13 Despite improvements in operative technique and anesthetic
support, operative mortality after open repair continues to range from 3% to 8%.14
Strategies for aneurysm repair took a drastic deviation with the initial descriptions
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Figure 1 Thoracoabdominal aneurysm classification.
Notes: Type I extends from the left subclavian artery to the celiac axis. Type II extends from the left subclavian artery and includes the infrarenal abdominal aorta to the level
of the aortic bifurcation. Type III extends from the sixth intercostal space to the iliac bifurcation. Type IV extends from the visceral abdominal aorta to the iliac bifurcation.
Type V extends from the sixth intercostal space to just above the renal arteries. Reprinted from The Annals of Thoracic Surgery, 67(6), Safi HJ, Miller CC 3rd, Spinal cord
protection in descending thoracic and thoracoabdominal aortic repair, 1937–1939, Copyright © 1999, with permission from Elsevier.5

of transfemoral treatment in 1991.15 Continued efforts to
expand the use of this technology and reduce morbidity
and mortality of TAA repair led to the first endovascular
exclusion reported in 1994. 16 The US Food and Drug
Administration (FDA) approved the first thoracic endograft
in 2005. Current endovascular techniques include debranching procedures whereby proximal or distal landing zones
are created by the construction of extra-anatomic bypass to
either visceral or arch vessels.17 Another common approach
includes the utilization of chimneys, or snorkels, to preserve flow to side branch vessels.18 Both represent viable
options in the absence of more mature endovascular devices.
With the recent availability of fenestrated and side branch
devices, the envelope of totally endovascular TAA repair has
again been pushed.19 Unfortunately, many of these devices
require custom fabrication, resulting in a delay of many
weeks until treatment can be delivered. Ultimately, the total
endovascular repair of complex TAAs will depend on the
availability of a usable, modular, off-the-shelf device.20 In
this paper, we will review the current state of endovascular
TAA repair technology, including hybrid solutions and
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total endovascular treatment options for this complex and
challenging disease.

Patient selection and evaluation
Elefteriades and Botta have nicely outlined guidelines for
intervention for TAAs in their recent publication (Table 1).21
These indications include: 1) rupture, 2) acute dissection,
3) persistent symptomatic state, 4) rapid growth, and
5) absolute size criterion. In the urgent and emergent setting, one does not have the luxury of a complete preoperative evaluation and risk factor management; however, in the
elective patients, a standardized work-up for aortic surgery
should be completed. This should include pulmonary, cardiac,
and renal evaluations. Pre-existing renal insufficiency has
been shown to be an independent predictor for postoperative morbidity and mortality in multiple studies.22–24 With
the added use of nephrotoxic contrast agents essential to
endovascular procedures, this common comorbidity becomes
even more important. In addition, patients may also undergo
spinal magnetic resonance angiography (MRA) to identify
important intercostal arteries to attempt to salvage during
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Table 1 Criteria for thoracoabdominal aneurysm intervention
Criterion

Specific description

Aneurysm rupture

As identified on radiographic studies or as
clinically apparent
Including ascending aorta or distal aorta with
malperfusion of visceral end organs or lower
extremities
Including localized pain, adjacent organ
compression, and/or aortic valvular insufficiency
Defined as growth $1 cm/year
Known connective tissue disorder
– Ascending: .5.0 cm
– Descending: .6.0 cm
No known connective tissue disorder
– Ascending: .5.5 cm
– Descending: .6.5 cm

Acute dissection

Persistent
symptomatic state
Rapid growth
Absolute size

Notes: Specific criteria for intervention on thoracoabdominal aneurysms include
the major categories of rupture, dissection, symptomatic nature, rapid growth,
and standard progressive degenerative dilation. Adapted from Surg Clin North Am,
89(4), Elefteriades JA, Botta DM Jr, Indications for the treatment of thoracic aortic
aneurysms, 845–867, Copyright © 2009, with permission from Elsevier.21

the risk of CIN is clearly linked to the amount of contrast
and pre-existing renal function, there is a very real risk of
precipitous renal function decline and potential dialysis in
any patient with a multitude of risk factors. These risk factors
include diabetes, age over 75 years, periprocedural volume
depletion, heart failure, cirrhosis or nephrosis, hypertension,
proteinuria, recent use of nonsteroidal anti-inflammatory
drugs, and intra-arterial injection of contrast as opposed to
intravenous.37,38 Many of these risk factors are present in
our TEVAR populations. With the increasing complexity of
cases treated via endovascular techniques, contrast utilization
increases as well. As such, we must employ careful and conscious strategies to decrease the volume of these nephrotoxic
agents, both intraoperatively and postoperatively.39

Cerebrovascular accidents

long segment coverage. If possible, staged repair has been
shown to reduce the incidence of postoperative paraplegia,
by allowing collateral pathways to the anterior spinal artery
to mature during serial interventions.26,27 Computed tomographic angiography of the aorta and branch vessels with
three-dimensional reconstruction and postprocessing image
manipulation software are essential tools when advanced
endovascular techniques are being utilized.28 True centerline
measurements and multiplanar reconstructions are essential in the accurate evaluation and planning, including the
evaluation of proximal and distal landing zones, the degree
of aortic tortuosity, the relationship of the aneurysm to arch
and visceral branch vessels, and the size and quality of the
access vessels.

Neurological complications, including stroke and spinal cord
ischemia, still remain one of the most dreaded challenges
facing thoracic aneurysm repairs regardless of the type
of surgical approach. The rate of stroke with thoracic
aneurysm repair ranges from 3% to 5%.29,30 The potential
etiologies include instrumentation of the aortic arch leading
to embolization or coverage of arch branches critical for
cerebral perfusion. A critical knowledge of vertebrolateral
dominance is crucial during planning and deployment.
Pre-emptive carotid subclavian bypass or transposition
may be necessary in a nonemergent situation.40 In addition,
activated clotting time (ACT) measurements should be taken
at baseline and complete anticoagulation should be confirmed
before any wire or catheter instrumentation of the aortic arch
is attempted.

Complications

Paraplegia

Complications associated with thoracoabdominal thoracic
endovascular aneurysm repair (TEVAR) include stroke
(3%–5%), paraplegia (up to 6%), access site complications (6%–14%), endoleaks (9%–38%), device migration
(0.7%–3.9%), graft collapse (rare), and persistent aneurysm
sac enlargement (7.1%–14.5%).29–36 As teams progress along
the learning curve and gain experience with preoperative
planning and graft deployment techniques, the rates of these
complications tend to diminish.

In the FDA stent graft trials, spinal cord ischemia and paraplegia rates were diminished with endovascular repair compared
to the open approach with a cumulative advantage of 6% versus 10%.33,34,41 Despite mild improvement in spinal cord ischemia, most experts recommend the routine use of spinal cord
protective techniques for endovascular thoracic aneurysm
repairs extending greater than 15 cm or those within 5 cm
of the celiac axis. We have previously shown that with aggressive protective measures, the incidence of spinal ischemia
can approach 1%.42,43 Our paraplegia reduction strategies
are multimodal and proactive. Management includes routine
spinal fluid drainage (spinal fluid pressure <6 mmHg during intraoperative aortic occlusion/exclusion), avoidance of
hypotension (mean arterial pressure 90–100 mmHg during

25

Renal failure and contrastinduced nephropathy
A 2006 review of contrast-induced nephropathy (CIN)
estimated the risk of CIN to be between 8%–14.5%.37 While
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and after reperfusion), and perioperative administration
of the excitatory neurotransmitter inhibitor naloxone.
Spinal drains are routinely left in place for 48 hours, unless
clinical parameters mandate longer drainage intervals. The
spinal drains are capped when lower extremity motor function is consistently demonstrated. In addition to the interventions above, systemic steroids are administered shortly
after anesthesia induction, and mannitol is given just before
endovascular device deployment. The ability to stage repair
has also been shown to effectively reduce paraplegia rates,
presumably by allowing collateral pathways to mature and
augment the spinal perfusion.27

Graft collapse
Graft collapse is perhaps the most catastrophic and potentially lethal endovascular device failure.44 Often, this failure
can result in rapid and potentially complete thoracic aortic
occlusion, and has been associated with acute spinal ischemia, limb malperfusion, and renovisceral malperfusion
syndromes.45,46 Potential factors contributing to this device
failure include small aortic landing zone diameters, aggressive oversizing, small radius curvature of the thoracic aorta,
and “bird-beaking” of the proximal seal zone, as often seen
in young patients with trauma-related aortic injuries. 47–49
A recent paper helped to elucidate and quantify the shear
forces related to proximal malapposition (“bird-beaking”)
of endografts, and provide the basis for patient-specific
modeling to define at-risk endoprosthesis.50 If diagnosed and
treated expeditiously, most at risk of collapsed grafts can be
treated with high radial force interventions, including Palmaz
stent placement.51

Access complications
Bilateral access is usually obtained and often requires a
24-French profile, which equates to at least an 8 mm access
diameter for safe delivery. Attention must be given to significant atherosclerotic narrowing or calcification of the external
iliac arteries to prevent damage to the vessel during delivery
or removal. An additional option includes a small retroperitoneal cutdown to expose the common iliac artery to create a
conduit. Other authors have advocated the use of controlled
iliac rupture after the placement of an endoconduit.52

Endoleaks
Endoleaks remain a challenging part of endovascular repair.
Since their first descriptions in the late 1990s, the classification remains largely unchanged.53,54
• Type Ia: Proximal seal failure.
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• Type Ib: Distal seal failure.
• Type II: Retrograde branch vessel filling of sac.
• Type III: Failure of device component seal or graft
fabric tears.
• Type IV: Graft porosity failure.
Thoracoabdominal endovascular repair remains a viable
option for failed standard infrarenal repair. As Martin et al
described, branched and fenestrated devices have a role in
salvage of late failure of proximal type Ia endoleaks in
infrarenal devices.55 As one would imagine, with the increasing number of components required to complete total
endovascular thoracoabdominal repairs, the incidence of
intercomponent failures increases, leading to higher rates of
type III endoleaks. This has been estimated as high as 9.3%
in recent series.56 The same group published their “lessons
learned” in dealing with these complex secondary interventions, including recommendations for technical changes and
planning during the index operation.57

Total endovascular repair
Standard TEVAR
The current FDA-approved devices for TEVAR include the
TAG graft and C-TAG (WL Gore, Flagstaff, AZ, USA), the
Talent device (Medtronic, Santa Rosa, CA, USA), the Bolton
Relay thoracic graft (Bolton Medical, Sunrise, FL, USA),
and the Cook TX2 (Cook Medical, Bloomington, IN, USA).
The proximal and distal landing zones must be accurately
measured. Most grafts require 10% to 20% oversizing of the
seal zone diameter. The distal landing zone is usually smaller
than the proximal zone, which often results in the use of
multiple grafts to adjust for this size difference or the use of
a tapered graft. The tendency of the stent graft to follow the
greater curvature of the aorta and the natural tortuosity of
the vessel often leads to an underestimation of the coverage
length. It is important to consider these factors when measuring and planning deployment. Occasionally, Zone 2 or
even more proximal landing zones are needed to accomplish
adequate seal (Figure 2). Debranching procedures are discussed in detail in the Hybrid Repair Section of this text.
It is generally recommended to have at least 2 cm of seal
zone at either end of the graft to prevent migration. If there
is severe angulation, calcification, or thrombus, the seal
zone length may need to be extended. Accurate deployment
positioning can be improved by performing aortography
at an oblique projection of 40 to 60 degrees. Additionally,
it is important to apply constant forward pressure during
deployment to allow the graft to conform along the outer
curvature of the aorta and prevent graft jump. Completion
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aneurysm, found that the 30-day mortality for elective TEVAR
was 5.3%.31 The US multicenter trials also showed a significant
improvement in mortality with endovascular repair at 2%
versus 6% for open repair.32 Additional studies comparing
elective endovascular versus open repairs have found overall
mortality rates that were higher than those reported in the multicenter trials, yet still favored the endovascular approach.58,59
In terms of ruptured descending thoracic aneurysms (DTAs),
multiple meta-analysis found improved mortality with endovascular repair ranging from 19% for TEVAR versus 33% for
emergent open repair.58,60,61

Branched endografts

Figure 2 Zones of the aortic arch.
Notes: Proximal landing zone attachment sites for endovascular graft deployment.
Reprinted from Surg Clin North Am, 89(4), Adams JD, Garcia LM, Kern JA,
Endovascular repair of the thoracic aorta, 895–912, Copyright © 2009, with
permission from Elsevier.93

aortography will confirm exclusion of the aneurysm and
allow evaluation for endoleak (Figure 3).
The combined EUROSTAR and UK thoracic endograft
registries, which included 249 patients with degenerative

Total endovascular repair of thoracoabdominal aortic aneurysms requires a strategy for preservation of any involved
branched vessels, specifically the reno-visceral branches. For
the most part, strategies have focused on creating a branched
configuration in the endograft (Figure 4). One method to
create branch points in an endograft is to use a combination
of reinforced fenestrations and balloon-expandable covered
stents. The proximal end of the covered stent is then flared
at the site of the reinforced fenestrations to create a gasket
seal. Another method is to use dedicated side branches
incorporated into the endograft itself. The dedicated side

Figure 3 Salvage TEVAR.
Notes: Salvage of failing prior open aortic transection repair using standard TEVAR technique. This 62-year-old patient had had a previous open aortic transection repair
at the age of 18 years after a motor vehicle crash. Nearly 45 years later, he presented with acute onset left sided chest and back pain. On CTA he was found to have a
pseudoaneurysmal contained leak at his previous anastomotic suture line (A). A single TEVAR device was deployed to cover the suture line pseudoaneurysm (B). His pain
resolved and is event free 2 years later.
Abbreviations: TEVAR, thoracic endovascular aneurysm repair; CTA, computed tomographic angiography.
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Figure 4 Branched endovascular devices.
Notes: The Zenith t-Branch device (A) (Cook Medical, Bloomington, IN, USA) is designed with four downward projecting branched access limbs. It deploys via a preloaded
22-F delivery system. The superior mesenteric artery branch limb measures 8 mm wide by 18 mm long, and the celiac artery branch measures 8 mm wide by 21 mm long.
The renal side branches measure 6 mm wide by 18 mm long. Above is an example of a complex aneurysm both before (B) and after (C) t-Branch endovascular treatment.
Copyright © 2013 International Society of Endovascular Specialists. Reproduced from Bosiers MJ, Bisdas T, Donas KP, Torsello G, Austermann M. Early experience with the
first commercially available off-the-shelf multibranched endograft (t-branch) in the treatment of thoracoabdominal aortic aneurysms. J Endovasc Ther. 2013;20(6):719–725.65

branches are usually extended into the target vessels using
self-expandable covered stents, which themselves are often
reinforced with a bare stent to prevent kinking.
Greenberg et al reported on their experience using various
combinations of these two approaches in 406 patients with
thoracoabdominal aneurysms, as well as 227 patients with
juxtarenal aneurysms.62 Reinforced fenestrations were the
preferred method for renal branches given the angulation
of these branches in reference to the aortic centerline. They
were also the preferred method for visceral branch preservation in type IV thoracoabdominal aneurysms. Dedicated side
branches were used for visceral preservation in type II and III
aneurysms if the lumen of the aorta was greater than 35 mm in
diameter at the visceral level and no dissection was present.
In this series, perioperative mortality was 1.8% for juxtarenal aneurysms, 2.3% for type IV aneurysms, 5.2% for
type II and III aneurysms, and 12.5% for type I aneurysms.
Late complications included rupture in five patients. In addition, branch vessel occlusion was seen in 2.3% of reinforced
fenestrations at 15 months follow-up and in one side-arm
branch. Postoperative sac behavior and endoleak rates were
not reported.
In another large series by Haulon’s group, 89 patients with
TAAs were treated using an endovascular approach similar
to Greenberg’s.63 The TAAs were classified as type I in four
patients, type II in 15 patients, type III in 25 patients, and
type IV in 45 patients. To this series, reinforced fenestrations
were used for 123 renal arteries, 54 superior mesenteric
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arteries, and 15 celiac arteries. Dedicated side branches were
used for 40 renal arteries, 33 superior mesenteric arteries,
and 29 celiac arteries.
Technical success was achieved in 96.6% of the cases. The
failures were related to target vessel loss in three patients. Two
of these three patients had target vessel loss in more than one
vessel, bringing the total to five target vessels. Perioperative
mortality was 8.9%. There were no late ruptures in this
cohort. At a median follow-up of 17 months, 22 endoleaks
were identified (three type III and 19 type II). Sac behavior
was not reported.
One of the disadvantages of this approach is the need for
custom-designed grafts for each patient. Not only is the commercial availability of these devices limited, but the time frame
for manufacturing these devices is generally considered to be
in the range of 6 to 8 weeks, which precludes urgent or emergent cases. The t-Branch device (Cook Medical) was released
to parts of the world in 2012 as a potential off-the-shelf design
utilizing four downward-oriented renovisceral side branches.
However, feasibility studies have suggested that this device
can still only be used to treat between 63% to 83% of cases
of thoracoabdominal aneurysms, even when combined with
adjuvant procedures such as carotid-subclavian bypass or
additional thoracic endografting.20,64 Regardless, Bosiers et al
reported uniformally excellent results in their early experience
of 15 patients treated with this device.65
Surgeon-modified devices have been proposed as an
alternative to commercially designed devices to further
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increase patient applicability without undue manufacturing
delay. However, the reported experience with these techniques is quite limited at present. Ricotta et al reported their
experience with surgeon-modified endografts in a cohort that
included eight thoracoabdominal aneurysms.66 Reinforced
fenestrations were used for all branches. There was one
perioperative death in the group secondary to subarachnoid
hemorrhage and one type III endoleak that required early
reintervention. At mean follow-up of 9 months, no other
type I or III endoleaks were observed. There was one type II
endoleak. There were no cases of postoperative rupture or
significant sac growth. Sac regression was observed in 64%
of the total cohort. In a case report, Oderich et al recently
described the technique of minicuff reinforced fenestrations
using 3–5 mm lengths of smaller stent grafts to create something more akin to a dedicated side branch.67 The authors
recommend this modification for TAAs with a larger luminal
diameter in the visceral segment, specifically those in which
the gap between the aortic endograft and the aortic wall is
greater than 10 mm.
While these reports certainly attest to the feasibility of
surgeon-modified branched grafts, the device planning and
technical expertise for success in these cases should not be
underestimated. Further, the effect of such modifications
on the integrity of the parent device is unknown. Finally,
depending on the locality, there are often medicolegal
regulations for physician-modified devices that need to be
addressed by the sponsoring institution prior to undertaking
such a program.

Parallel and molded parallel endografts
Another popular option for branch vessel preservation
during complex aneurysm repair is to use parallel endografts
(Figure 5). Two recent publications summarized early results
with parallel endografts.18,68 These papers included mostly juxtarenal pathologies, but did demonstrate a technical success rate
of 98.9%.68 Additionally, they found a 97.8% patency rate at a
mean follow-up interval of 9 months.18 While these techniques
have been more commonly used for juxtarenal pathologies (ie,
the so-called “chimney” or “snorkel” technique), the concept
can be applied to TAAs by utilizing a standard endograft as
the landing zone for the parallel endografts. This configuration
has been referred to as the “sandwich” technique. The technique has been championed by Lobato and Camacho-Lobato,
who recently reported a very large series of such cases that
included 13 elective and two emergent TAA repairs.69 One of
the elective thoracoabdominal cases was aborted when neither
renal artery could be cannulated. In the remaining 14 cases, a

Vascular Health and Risk Management 2014:10
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Figure 5 Parallel endografts.
Notes: Postoperative three-dimensional volume rendering of a type II thoraco
abdominal aneurysm treated with parallel endografts. The visceral stents were
placed antegrade via left axillary access. The renal stents were placed retrograde via
contralateral femoral access.

total of five target vessels were sacrificed for various reasons,
while 43 were successfully preserved. Perioperative mortality
was 8% in the elective group, with the one death related to
hepatic failure in a patient whose celiac artery was intentionally
occluded after performing a viability test. The two emergent
repairs were performed for rupture and both died in the postoperative period from colonic infarction. One was secondary
to an intraoperative SMA dissection and subsequent occlusion,
while the other was apparently from hemodynamic instability.
At mean follow-up of 16 months, there were no late target
vessel losses. Intraoperatively, there was one type I and two
type III endoleaks. However, they subsequently resolved. There
was no late postoperative rupture or sac growth. Significant sac
reduction was observed in all patients who had been followed
for at least 24 months.
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While these results are far from perfect, they are
comparable to what has been reported for more conventional
branched configurations. Unfortunately, the small numbers
preclude direct comparison between the two techniques.
However, there are theoretical advantages and disadvantages
that deserve consideration. The big advantage of parallel
endografts is that they are completely modular, providing
an off-the-shelf option for almost any anatomy without the
need for device modification.
Another advantage is that the branch vessels are cannulated
prior to deployment of the aortic endoprosthesis. This advantage can be quite important in three situations. The first is in
tortuous anatomy, where alignment of a fenestration or side
branch to the target vessel can be very difficult. The second
is in small lumens, such as dissections, in which the aortic
device may remain partially compressed. The third is when
there is significant thrombus in the paravisceral aorta, placing
the patient at risk for atheroembolization during deployment
of the aortic endoprosthesis. It should be noted that at least
one quarter of the perioperative deaths in Haulon’s series63
of conventional branched grafts were from this etiology.
In theory, these deaths may have been prevented if parallel
endografts had been used and the renovisceral-covered stents
deployed prior to the aortic endoprosthesis.
This distinction is a two-edged sword, though, because
one of the disadvantages of parallel endografts is that
all branch vessels must be cannulated prior to the aortic
endoprosthesis. This requirement poses some logistical issues
in terms of access. While Lobato described using bilateral
axillobrachial access to accommodate the four renovisceral
sheaths, our preference has been to use retrograde-covered
stents in the renal arteries placed from sheaths in the contra
lateral groin and unilateral (left) axillobrachial access for the
sheaths used for the visceral stents.
The big disadvantage of parallel endografts, however, is
the imperfect seal inherent to the technique. The side-by-side
configuration leads to gutters along the parallel endografts,
which can result in endoleaks and continued pressurization
of the sac.
Many will contend that the gutters can be eliminated by
oversizing the aortic stent so that it wraps around the branch
stent. In reality, though, endografts are simply not designed
to deploy in such a manner. Further, the effect of postballooning is to make the devices more round. In vitro studies
have shown that 40% oversizing of the aortic stent can best
minimize (but still does not eliminate) the gutters along a
single parallel branch stent. However, this approach also led
to significant infolding, leaving the authors to recommend
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30% oversizing and accepting larger gutters.70 Using this
amount of oversizing without achieving the prime objective
is just not a practical strategy, let alone a feasible one, in
larger aortas with multiple parallel endografts.
Alternatively, Lobato has suggested overlap lengths of at
least 5 cm to induce thrombosis of the gutters. In our personal
experience, though, we have seen persistent endoleaks with
even 10 cm of overlap. Further, longer overlap lengths may
affect patency rates and sometimes necessitate sacrifice of
additional lumbar or intercostal vessels.
Our contention is that the gutters can be eliminated by
molding the parallel graft into an eye-shape (as opposed to
leaving it a round shape) so that the aortic graft can more
easily conform to its exposed perimeter.71 We refer to this
maneuver as the “eye of the tiger” technique (Figure 6).
For the “eye of the tiger” method, a balloon-expandable
covered stent (iCAST; Atrium Medical Corporation, NH,
USA) is deployed in the target branch vessel alongside a
standard aortic endograft. The parallel portion of the iCAST
is then postdilated by a factor of approximately 1.6 and the
balloon is exchanged back for the original sized balloon. The
iCAST is then crushed using a seating balloon in the aortic
endograft to establish complete apposition of all perimeters.
The central portion of the iCAST is then reinflated with the
original sized balloon, creating an eye shape. Kissing balloon angioplasty at low inflation pressures (∼2 atm) then
completes the molding. The target length of overlap should
be at least as much as that recommended for overlapping
aortic devices.
Once the branch stent is molded into an eye-shape, it
creates a luminal irregularity resembling that of a perfectly
smooth atherosclerotic plaque, which is a shape that aortic
endografts are much better designed to conform to.
In addition, the eye shape essentially represents two arcs
intersecting at acute angles. The geometric term for this shape
is a lens. If a lens is perfectly symmetrical, then by definition
the two arcs are of equal length and radius. Therefore, the
arc that the aortic endograft must conform to is exactly the
same length as the arc that it would have had to conform to if
the eye-shaped stent was not present. The only difference is
that the arc is now convex rather than concave. The implication of this symmetry is that no additional oversizing of the
aortic endograft is necessary. However, since symmetry is
not always achieved, some oversizing is recommended.
Finally, it is important to note that we, like many others,
have found that a seal can often be achieved with standard
tube-shaped parallel endografts, especially when there is minimal potential outflow for any gutter leak. In these cases, we
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Figure 6 Molded TEVAR.
Notes: Postoperative computed tomography scan of a type V thoracoabdominal aneurysm treated with a single parallel graft to the celiac artery. The parallel graft has been
molded to an eye-shape more proximally in the overlap zone to allow for perfect apposition of the multiple endoprostheses and elimination of any potential gutters (A). The
parallel graft remains round more distally in the overlap zone near the origin of the celiac artery. Note the large gutters (B) that would have likely resulted in an endoleak if
this covered stent had not been molded to an eye-shape more proximally.
Abbreviation: TEVAR, thoracic endovascular aneurysm repair.

usually test the waters with a standard parallel configuration,
then only proceed with the “eye of the tiger” maneuver if
there is persistent intraoperative type III endoleak.

Hybrid repair
The hybrid technique involves extra-anatomic debranching
combined with staged or immediate endovascular aortic relining using covered aortic stent grafts (Figure 7). This combined
approach was first performed in 1999 by Quiñones-Baldrich

Figure 7 Arch debranching.
Notes: Creation of a proximal landing zone can be accomplished with arch
debranching. In this case, a left subclavian to left common carotid transposition
(arrow) was created in anticipation of a Zone 2 proximal landing zone for subsequent
TEVAR. Others have described the addition of carotid-carotid bypass to allow Zone
1 proximal landing zone creation.
Abbreviation: TEVAR, thoracic endovascular aneurysm repair.

Vascular Health and Risk Management 2014:10

et al in a patient with a Crawford type IV TAA in order to
avoid the morbidities associated with an open repair.72
The choice of open verses hybrid approach is dependent
on the patient’s comorbidities, including the presence of
severe COPD, the inability to tolerate a left thoracotomy,
previous open thoracic operations, the presence of severe renal
insufficiency, and cardiac impairment that would not tolerate
proximal aortic clamping.73,74 By avoiding thoracotomy, extracorporeal perfusion, aortic cross-clamping, and single lung
ventilation, the hybrid procedure has been suggested to have
decreased mortality in high-risk patients.73,75 Other literature
has suggested that the hybrid repair has no significant difference in outcomes when compared to open TAA repair.76–78
In approximately 20% of cases, the proximal seal zone
can only be achieved by extending across the left subclavian artery origin.79 Current Society for Vascular Surgery
guidelines recommend preoperative left subclavian revascularization in elective TEVAR and expectant management
in acute settings, though this remains an area of debate.40
The presence of a left dominant vertebrobasilar system or
the existence of a left internal mammary coronary artery
bypass graft are strong indications to consider pre-emptive
carotid-subclavian bypass or transposition in the elective
intervention. Others advocate for reactive revascularization
only if arm claudication or subclavian steal occurs after routine covering of the origin. It should also be noted that the left
subclavian can be an important input to the collateral network
feeding the anterior spinal artery, and as such, if other inputs
are diseased or excluded, direct revascularization should be
strongly considered.
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For the majority of hybrid TAA repairs, the proximity
of the celiac, SMA, and renal arteries to one another will
mandate visceral bypasses. Selective celiac artery coverage
is feasible, but recent studies found a bowel ischemia rate
of approximately 6% and an endoleak rate of approximately
16%.80,81 It is feasible to consider only mesenteric debranching in patients with pre-existing renal failure on dialysis.
In general, the anatomy of the aneurysm will indicate the
optimal origin for the retrograde bypass. For example, in a
Crawford type I TAA, the native infrarenal aorta or a common iliac artery will provide a suitable graft origin. However,
a Crawford type II or III TAA with contiguous dilation from
the thoracic aorta throughout the common iliac vessels makes
a hybrid repair challenging, and is best repaired with traditional open or total endovascular techniques.
The retrograde debranching is often performed using multi
sidearm surgical grafts (Figure 8). Two of the limbs can be
used to bypass to the right and left renal arteries, with the third
limb being anastomosed to the SMA in an end-to-side fashion.

A jump graft is then created from this limb to the celiac axis.
When creating the celiac artery anastomosis, the hepatic or
splenic artery should be used because the exposure to the
celiac bifurcation is difficult and leaves little room to ligate
the main celiac trunk. It is necessary to ligate the origins of
each debranched vessel to prevent a type II endoleak.
Staging of the hybrid repair is often necessary due to
the long and technically demanding nature of the debranching procedure. This is especially true in the type II and III
TAAs. The endovascular portion of the procedure should
be performed as soon as the patient has recovered from
the debranching procedure. It is advised that the staged
procedures be performed during the same admission given
that interval aneurysm rupture has been reported when
patients are discharged after debranching.75,82 Some have
advocated placing a conduit limb (10 mm diameter) into
the subcutaneous tissues of the lower abdominal wall. At the
time of the secondary endovascular procedure, a small lower
abdominal incision is made and the conduit limb is delivered

Preop

Abdominal
debranching

PostTEVAR

PostTEVAR

Figure 8 Multivisceral abdominal debranching.
Notes: Creation of a distal landing zone can be accomplished with abdominal debranching procedures. Celiac, SMA, and either or both renal arteries (arrows) can be
debranched to facilitate TEVAR landing zones. Recent introduction of hybridized grafts has simplified this procedure.94 In addition, in those patients with poor access vessel
diameter, a conduit limb can be tunneled into the anterior abdominal wall and left in place for future exposure, thrombectomy, and controlled access for later TEVAR
introduction.
Abbreviations: Preop, preoperatively; SMA, superior mesenteric artery; TEVAR, thoracic endovascular aneurysm repair.
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and thrombectomized. It can then be used to cannulate and
deploy the thoracic grafts.
There have been numerous case series evaluating the
outcomes of hybrid TAA repairs. The Crawford type and
emergency nature of these repairs must be taken into account
when comparing outcome data. Overall, the 30-day mortality
rates for the hybrid repair range from 0%–31%. The morbidity ranges from 17%–56%, with a paraplegia risk of 0%–10%
and graft occlusion rate ranging from 0%–13%.74,83–92 In one
of the largest series to date (n=107), Drinkwater et al had the
highest number of type II (n=45) and III (n=32) TAA with a
mortality rate of 15% and morbidity of 38%.87 Concordant
with the complexity of these repairs, they reported a rate of
spinal ischemia of 12.1% and a rate of permanent paraplegia
of 8.4%. Long-term dialysis was needed in 3.7% of patients,
and 2.8% of the patients had an infarcted segment of bowel
requiring resection. None of the cases in the Drinkwater series
were emergent.87 The case series from Muehling’s group out
of Germany had 16 patients and reported the highest rate
of emergency cases (38%). They reported a mortality of
31% and morbidity of 44%, with a paraplegia rate of 6%.90
Quiñones-Baldrich’s group reported a series of 20 patients
with no mortalities at 30 days, a mean follow-up of 16.6
months, and an overall survival of 75%.84
The breadth of data indicates that the hybrid approach to
TAA pathology is a reasonable option for high-risk patients.
Patient selection and careful preoperative planning is crucial
to the success of this approach.

Summary
As endovascular devices continue to mature, the breadth
of patients that can be treated by total endovascular TAA
repair continues to increase. In the absence of modular
off-the-shelf devices, these custom-designed branched
devices are limited in application to elective cases. However,
as these technologies improve and operator learning curves
advance, we can expect to treat an increasing population
with total endovascular techniques. Hybrid options remain a
viable alternative in those patients who require creation of a
definitive landing zone.
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